The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, Massachusetts ...

Axe falls on Stealth Bio staff after FDA rejects lead drug Stealth BioTherapeutics' chief executive Reenie McCarthy.